1315 Capital II, L.P.

Shareholder

Related company / holding

US·SEC (Form 4)

Interpace Biosciences, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 17 Feb 2026 for Interpace Biosciences, INC., €16.3M. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

1315 Capital II, L.P.: trading record in brief

Our data holds just one disclosure by 1315 Capital II, L.P., dated 17 February 2026, reporting a transaction worth €16.3M in Interpace Biosciences, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to 1315 Capital II, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Interpace Biosciences, Inc. (US)

Declarations1 total

●

1315 Capital II, L.P.

Related company / holdingExecutives20 Jan 2026Interpace Biosciences, Inc.

19M USD13SEC ↗

9,405,941 shares@ US$2.02100.0% of flowCommon StockSEC:0001493152-26-007093:0

1 of 1 declaration

1315 Capital II, L.P.

Insider track record

1315 Capital II, L.P.: trading record in brief

Companies and markets linked to 1315 Capital II, L.P.

Related entities

1315 Capital II, L.P.

Insider track record

1315 Capital II, L.P.: trading record in brief

Companies and markets linked to 1315 Capital II, L.P.

Related entities